Top 10 Alternatives to VUNO Med-Fundus AI Recently Reviewed By G2 Community
AI can help you find the answers. G2 helps you trust them.
Connect G2 to Claude or ChatGPT for answers grounded in G2's trusted reviews, comparisons, and pricing from real user insights.
How it works
OpenEvidence is a medical information platform designed to assist healthcare professionals in navigating the vast and rapidly expanding body of medical research. Originating from the Mayo Clinic Platform Accelerate program, it integrates multimedia and clinical findings from esteemed sources like The New England Journal of Medicine. By aggregating, synthesizing, and presenting clinically relevant evidence in accessible formats, OpenEvidence empowers medical practitioners to make informed, evidence-based decisions, ultimately enhancing patient outcomes.
PathAI Products and Services. Evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.
Viz.ai is the leader in building and deploying AI-powered Care Pathways and helping doctors do their work. The Viz Platform is deployed in 2,000 hospitals across the United States and trusted by many of the leading life sciences companies. The platform uniquely combines real-time, multimodal clinical data with deep clinician engagement to detect disease earlier, coordinate care teams, and help ensure patients receive the right treatment faster. Viz.ai was the first company to be awarded CMS reimbursement for AI and is ranked the #1 Healthcare AI Platform by hospitals and health systems in the Black Book Research survey.
Qure.ai is a pioneering health technology company that leverages artificial intelligence (AI to enhance the accuracy and efficiency of medical imaging diagnostics. By integrating deep learning algorithms with existing radiology equipment, Qure.ai provides automated interpretation of X-rays, CT scans, and ultrasounds, delivering results within seconds. This rapid analysis empowers healthcare professionals to make timely, informed decisions, ultimately improving patient outcomes and making quality healthcare more accessible and affordable worldwide. Key Features and Functionality: - qXR: An AI-driven tool that analyzes chest X-rays to detect over 30 abnormalities, including signs of tuberculosis and lung cancer, in less than a minute. - qER: Designed for brain CT scans, this solution aids in the rapid detection of traumatic brain injuries and strokes, facilitating quicker decision-making in emergency settings. - qCT: An AI-powered tool for chest CT scans, enabling early detection of lung nodules and other abnormalities, crucial for lung cancer screening programs. - qMSK: An innovative AI solution focused on identifying musculoskeletal abnormalities, including fractures, to assist in orthopedic diagnostics. - qTrack: A comprehensive disease management platform that offers end-to-end solutions for screening programs and case management, enhancing care coordination and monitoring through customized dashboards. Primary Value and User Solutions: Qure.ai addresses critical challenges in medical diagnostics by providing AI-powered tools that significantly reduce the time required for image interpretation, thereby expediting diagnosis and treatment. This is particularly vital in time-sensitive situations like stroke care, where rapid intervention can be life-saving. Additionally, by automating routine diagnostic tasks, Qure.ai alleviates the workload of radiologists, allowing them to focus on complex cases. The technology's compatibility with existing imaging equipment ensures seamless integration without the need for costly hardware upgrades, making advanced diagnostic capabilities accessible even in resource-limited settings. Overall, Qure.ai's solutions enhance diagnostic accuracy, streamline clinical workflows, and improve patient outcomes on a global scale.
Medicai enables small and medium clinics, doctors, hospitals, clinical studies, and patients to securely and asynchronously collaborate and access medical imaging and medical documents from anywhere. We resolve widespread industry compliance issues and provide a fully HIPAA and GDPR-compliant solution.
Nanox.AI is a suite of FDA-cleared artificial intelligence solutions designed to analyze routine medical CT scans and identify early signs of chronic diseases. By leveraging advanced AI algorithms, Nanox.AI assists clinicians in detecting asymptomatic, undiagnosed conditions, facilitating earlier diagnosis and preventive care. This proactive approach aims to improve patient outcomes and reduce the burden on healthcare systems. Key Features and Functionality: - HealthCCSng Cardiac Solution: Automatically detects coronary artery calcification (CAC from routine chest CT scans, aiding in the identification of patients at risk for coronary artery disease without the need for dedicated imaging. - HealthOST Bone Solution: Identifies vertebral compression fractures and low bone mineral density in chest and abdominal CT scans, assisting in the early detection of osteoporosis. - HealthFLD Fatty Liver Solution: Utilizes AI algorithms to detect signs of fatty liver disease in routine CT scans, enabling early intervention strategies. Primary Value and Problem Solved: Nanox.AI addresses the challenge of undiagnosed chronic conditions by extracting actionable insights from existing medical imaging data. Its AI-driven analysis enables healthcare providers to identify at-risk patients earlier in their disease progression, allowing for timely interventions and personalized preventive care plans. This not only enhances patient health outcomes but also optimizes healthcare resources by reducing the incidence of advanced disease complications.
Aidoc is a AI software that detects abnomalities on X-ray and scans.
5C Network is an AI-native radiology platform that integrates advanced artificial intelligence with human expertise to deliver rapid and consistent diagnostic imaging services. By managing the entire radiology workflow—from image ingestion and AI-powered detection to structured reporting and quality supervision—5C Network enhances diagnostic accuracy and efficiency. Serving over 1,500 healthcare facilities and processing more than 10,000 scans daily, the platform boasts an average turnaround time of 30 minutes, significantly reducing the industry standard of 24-48 hours. With a team of over 400 expert radiologists and AI trained on over 3 billion medical images, 5C Network ensures high-quality, timely, and accessible radiology services. Key Features and Functionality: - End-to-End Radiology Workflow: Manages the complete diagnostic process, including image ingestion, triage, reporting, quality control, and continuous improvement. - AI-Assisted Diagnosis: Utilizes AI to analyze various imaging modalities such as CT, MRI, X-ray, Mammography, and PET-CT, detecting and measuring 234 different pathologies with a 0.93 F1 score. - Rapid Turnaround: Delivers diagnostic reports with an average turnaround time of 30 minutes, enhancing patient care and operational efficiency. - Human-in-the-Loop Quality Supervision: Employs eight specialized quality control agents to validate every report, ensuring accuracy and consistency. - Continuous Learning: Improves diagnostic accuracy over time through a feedback loop that incorporates real-world corrections into the AI models. Primary Value and Solutions Provided: 5C Network addresses critical challenges in radiology by reducing diagnostic turnaround times, standardizing report quality, and expanding access to specialist-level reads across various imaging modalities. By combining AI-driven analysis with expert radiologist oversight, the platform enhances diagnostic accuracy and efficiency, ultimately improving patient outcomes and supporting healthcare providers in delivering timely and reliable radiology services.
Qure.ai's qXR-HF is an advanced AI-powered solution designed to facilitate the early detection of heart failure risk through the analysis of chest X-rays. By leveraging deep learning algorithms, qXR-HF identifies critical indicators such as cardiomegaly (enlarged heart) and pleural effusion (fluid accumulation), which are commonly associated with heart failure. This technology aims to enhance diagnostic accuracy, reduce the likelihood of late or missed diagnoses, and ultimately improve patient care outcomes.
Lunit, abbreviated from “learning unit,” is a Medical AI software company devoted to developing advanced medical image analytics and novel imaging biomarkers via cutting-edge deep learning technology. Founded in 2013, Lunit has been internationally acknowledged for its advanced, state-of-the-art technology and its application in medical images. Lunit is based in Seoul, South Korea.